Back to Results
First PageMeta Content
Heparins / Anticoagulants / Ketones / Deep vein thrombosis / Venous thrombosis / Pulmonary embolism / Edoxaban / Stroke / Atrial fibrillation / Medicine / Hematology / Chemistry


Microsoft Word - FINAL_SAVAYSA FDA Release - Limited AF Indication and Full VTE Approval .docx
Add to Reading List

Document Date: 2015-01-08 22:02:23

Open Document

File Size: 138,62 KB

Share Result on Facebook

City

Dallas / New York / Tokyo / Parsippany / Amsterdam / /

Company

Patient.co.uk / VTE Impact Assessment Group / New England Journal / Daiichi Sankyo Group / Daiichi Sankyo Inc. / Daiichi Sankyo Company Limited. / SAVAYSA / John Wiley & Sons / /

Continent

Europe / /

Country

Japan / United States / /

/

Event

FDA Phase / Product Issues / /

IndustryTerm

marketed pharmaceuticals / Care of Stroke / pharmaceutical / value chain / pharmaceutical products / /

MedicalCondition

Strokes / epidemic / intracranial hemorrhage / systemic embolism / ischemic stroke / Symptomatic Venous Thromboembolism / Atrial Fibrillation AF / permanent paralysis / pulmonary thromboembolism / pulmonary embolism / non-fatal and fatal venous thromboembolism / dyslipidemia and bacterial infections / cardiovascular diseases / non-AF related strokes / pulmonary arteries / arrhythmia / Stroke Associated With Atrial Fibrillation / About Venous Thromboembolism VTE / spinal deformity / hypertension / nonvalvular atrial fibrillation / disease / et al. Heart Disease / severe mitral stenosis / stroke / cardiovascular-metabolic diseases / Non-Valvular Atrial Fibrillation / deep vein thrombosis / thrombotic disorders / blood clot / Venous Thromboembolism / Atrial Fibrillation / Thrombosis / et al. Deep Vein Thrombosis / anemia / /

MedicalTreatment

orthopaedic surgery / orthopedic surgery / catheters / Hemodialysis / spinal surgery / /

Organization

Administration for SAVAYSA / Centers for Disease Control and Prevention / Congress / U.S. Food and Drug Administration / FDA / American Heart Association / European Union / Ministry of Health / /

Person

Joji Nakayama / Glenn Gormley / Van Beek / Michaela Paudler-Debus / Alyssa Dargento / /

/

Position

investigator / Executive Chairman and President / Kannel WB / Benjamin EJ / Representative / Director / President and Chief Executive Officer / Executive Officer and Global Head / /

Product

rifampin / Japan / renal function / /

ProvinceOrState

Prince Edward Island / /

PublishedMedium

the New England Journal of Medicine / /

Technology

pharmacokinetics / pharmacodynamics / /

URL

http /

SocialTag